Laboratorio Reig Jofre S A : Reig Jofre convenes its 2023 General Shareholders´ Meeting

CNMV

Edison, 4

28006 Madrid

Barcelona (Spain), February 28, 2023

OTHER RELEVANT INFORMATION

In accordance with Article 227 of Royal Legislative Decree 4/2015, dated 23 October, which enacts the consolidated text of the Securities Market Act, LABORATORIO REIG JOFRE SA ("Reig Jofre" or "the Company"), informs that on February 27, 2023, the Board of Directors of the Company approved the convening of the Ordinary and Extraordinary General Shareholders' Meeting on March 30th, 2023, at 11.00 h, on first call and, in the same location and at the same time on the following day, March 31th, 2023, if necessary, on second call, with the agenda attached hereafter.

The Board of Directors has also agreed to enable remote attendance at the Ordinary and Extraordinary General Meeting of Shareholders, allowing those shareholders who so wish to attend and participate in the General Meeting by remote connection and in real time, in accordance with the provisions of the Articles of Association and the Regulations of the General Meeting of Shareholders.

The General Meeting is expected to take place on first call, that is, on March 30th, 2023, at 11:00 a.m.

As per the Company's will to continue a shareholder remuneration policy, which is in turn compatible with ongoing growth projects, the Board of Directors of the Company will submit for the Shareholders' Meeting approval a scrip dividend or flexible dividend, allowing Reig Jofre's shareholders to receive, if they so wish, shares issued by the Company, but without limiting their possibility of receiving in cash an amount equivalent to the payment of the dividend, if that is their total or partial choice.

To that end, the Board of Directors shall submit to the Shareholders' Meeting a capital increase for an amount determined in accordance with the terms of the agreement, through the issuance of new ordinary shares with a nominal value of fifty cents and with provision for incomplete allocation.

Following the approval, if applicable, of such dividend by the Shareholders' Meeting, the Board of Directors shall approve its execution, as well as all the operational details thereof, at which time a new Relevant Fact shall be sent with all details concerning amount, deadlines and procedure.

All documentation related to the aforementioned and the rest of the agenda is available in the Investors / General Shareholders' Meeting section of the Company's website, www.reigjofre.com.

Yours faithfully,

Mr. Adolf Rousaud

Secretary non-director of the Board of Directors

NOTICE OF ORDINARY AND EXTRAORDINARY GENERAL MEETING OF

SHAREHOLDERS OF LABORATORIO REIG JOFRE, S.A.

The Board of Directors of LABORATORIO REIG JOFRE, S.A. (hereinafter the"Company"), on 27 February 2023, resolved to convene the Ordinary and Extraordinary General Shareholders' Meeting of the Company, to be held in Barcelona, at the Barcelona Stock Exchange Assembly Hall, Passeig de Gràcia, 19, on 30 March 2023, at 11:00 a.m. on first call and at the same place and time on the following day, 31 March 2023, if necessary, at second call.

The Governing Board also agreed to make permit remote assistance to the Ordinary and Extraordinary General Shareholders' Meeting, enabling shareholders who so wish to attend and participate in the General Shareholders' Meeting by remote connection and in real time, in accordance with the provisions of the Articles of Association and the Regulations of the General Shareholders' Meeting.

The General Meeting is scheduled to be held on first call, i.e. on 30 March 2023 at 11:00 a.m.

The General Meeting shall be held in accordance with the following:

AGENDA

ONE. Annual accounts and corporate governance:

1.1. Examination and approval, as the case may be, of the Company´s 2022 Individual Annual Accounts, duly reviewed by the Company's auditors.

1.2 Examination and approval, as the case may be, of the Company´s 2022 Individual Management Report, duly reviewed by the Company's auditors.

1. Examination and approval, as the case may be, of the 2022 Consolidated Annual Accounts of the Company and its subsidiaries, duly reviewed by the Company's auditors.
2. Examination and approval, as the case may be, of the 2022 Consolidated Management Report of the Company and its subsidiaries, duly reviewed by the Company's auditors.
3. Examination and approval, as the case may be, of the 2022 Consolidated Statement of Non-Financial Information.
4. Approval, if applicable, of the proposal for the application of the 2022 profits.
5. Approval, if applicable, of the corporate management carried out in 2022.

TWO. Submission of the 2022 Annual Report on Remuneration of the Company's Directors to a consultative vote.

3

THREE. Resignation of REIG JOFRE INVESTMENTS, S.L. as member of the Board of Directors and of the Appointments, Remuneration and Sustainability Committee and, appointment of Ms Isabel Reig López as a new Company director for the statutory term.

1. Resignation of REIG JOFRE INVESTMENTS, S.L. as a member of the Board of Directors and of the Appointments, Remuneration and Sustainability Committee.
2. Appointment of Ms Isabel Reig López as a new Company director for the statutory term.

FOUR. Re-election of the following members of the Company's Board of Directors:

1. Re-electionof Mr Alejandro Garcia Reig.
2. Re-electionof Ms María Luisa Francolí Plaza.
3. Re-electionof Mr Ramón Gomis de Barbarà.
4. Re-electionof Mr Ramiro Martínez-Pardo del Valle.
5. Re-electionof Mr Emilio Moraleda Martínez.
6. Re-electionof Mr Ignasi Biosca Reig.

FIVE. Re-election of the auditors of the Company and its Consolidated Group for 2023.

SIX.Approval, if applicable and within the "Reig Jofre Flexible Dividend" plan, of i) distribution of dividends charged to unrestricted reserves and, ii) increase in the Company's share capital charged to reserves for an amount to be determined according to the terms of the resolution, through the issue of new ordinary shares of fifty cents par value and with provision for incomplete allocation. Offer to Shareholders to purchase their free-of-charge allocation rights for a guaranteed price. Application for admission to trading of the issued shares. Delegation of powers to the Board of Directors, with express power of substitution, including, among other matters, the power to redraft the article of the Articles of Association regulating share capital.

SEVEN. Delegation of powers to the Board of Directors, with express power of substitution, for the formalisation, interpretation, correction and/or execution of the resolutions adopted by the General Meeting.

EIGHT. Other issues. Questions and Answers.

Holding of the General Shareholders' Meeting

4

Unless otherwise announced, the General Shareholders' Meeting is scheduled to be held on first call, i.e. on 30 March 2023, at the time and place indicated. Card registration will start one hour before the scheduled time of the General Shareholders' Meeting.

Since the General Meeting is expected to be held on first call, it is hereby noted that:

1. Shareholders must have the shares registered in their name no later than 23 March 2023 for the purposes of Article 517 of the Capital Companies Act.
2. Shareholders should have attendance cards no later than 23 March 2023.
3. Remote votes and proxies must be received by the Company no later than 23:59 p.m. on 23 March 2023.

Without prejudice to the foregoing, the Board of Directors reminds the Shareholders that they may participate in the General Shareholders' Meeting remotely, either by attending the Meeting electronically in real time, as described in this notice below, or by exercising their proxy and voting rights by remote means of communication prior to the General Shareholders' Meeting, under the terms also set forth in this notice.

In this regard, shareholders are hereby informed that they may exercise their rights of attendance, representation, information and voting at the General Meeting through the various means of communication described in this notice.

The right to request the publication of a supplement to the call and to submit reasoned proposals in accordance with the call for proposals

Pursuant to article 519 of the Capital Companies Act, Shareholders representing at least three per cent (3%) of the share capital may request the publication of a supplement to this notice of the General Shareholders' Meeting, including one or more items on the Agenda, provided that the new items are accompanied by a justification or, as the case may be, a justified proposed resolution. The exercise of this right must be effected by means of reliable notification, which must be received at the registered office within five (5) days following the publication of this notice. In turn, Shareholders representing at least three per cent (3%) of the share capital may, within the same period and in the same manner as indicated above, submit reasoned proposals for resolutions on matters already included or to be included on the Agenda of the General Meeting called. The Company shall ensure the dissemination of these proposed resolutions and any accompanying documentation to the other shareholders through its website.

Documentation available to shareholders and right to information.

In accordance with the provisions of the Capital Companies Act, the Articles of Association and the Regulations of the General Meeting, from the date of publication of this notice of call, Shareholders are entitled to examine the following at the registered office, view it on the Company's website (www.reigjofre.com) and request it be sent to them free of charge (which may be made by e-mail with acknowledgement of receipt if the shareholder agrees to this) of:

1. The convening notice.

5